| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.
|
Ann Rheum Dis
|
2012
|
4.81
|
|
2
|
Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight.
|
J Bone Miner Res
|
2004
|
3.77
|
|
3
|
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system.
|
J Rheumatol
|
2003
|
3.61
|
|
4
|
Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect.
|
Proc Natl Acad Sci U S A
|
2002
|
3.26
|
|
5
|
Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis.
|
Arthritis Rheum
|
2006
|
2.81
|
|
6
|
Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis.
|
Ann Rheum Dis
|
2007
|
2.81
|
|
7
|
Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study.
|
J Bone Miner Res
|
2004
|
2.21
|
|
8
|
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 3: an international multicenter reliability study using the RA-MRI Score.
|
J Rheumatol
|
2003
|
2.04
|
|
9
|
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 4: an international multicenter longitudinal study using the RA-MRI Score.
|
J Rheumatol
|
2003
|
1.65
|
|
10
|
Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
|
Curr Med Res Opin
|
2012
|
1.64
|
|
11
|
Cross-calibration and minimum precision standards for dual-energy X-ray absorptiometry: the 2005 ISCD Official Positions.
|
J Clin Densitom
|
2006
|
1.30
|
|
12
|
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.
|
Arthritis Res Ther
|
2011
|
1.22
|
|
13
|
Outcome assessment in clinical trials of fracture-healing.
|
J Bone Joint Surg Am
|
2008
|
1.19
|
|
14
|
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERACT 6 MR Imaging Module.
|
J Rheumatol
|
2003
|
1.07
|
|
15
|
Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment.
|
Curr Med Res Opin
|
2009
|
1.02
|
|
16
|
The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands.
|
J Rheumatol
|
2009
|
1.00
|
|
17
|
Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?
|
J Rheumatol
|
2009
|
1.00
|
|
18
|
Atypical form of active melorheostosis and its treatment with bisphosphonate.
|
Skeletal Radiol
|
2002
|
0.96
|
|
19
|
A multireader reliability study comparing conventional high-field magnetic resonance imaging with extremity low-field MRI in rheumatoid arthritis.
|
J Rheumatol
|
2007
|
0.88
|
|
20
|
Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring system.
|
J Rheumatol
|
2013
|
0.86
|
|
21
|
Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritis.
|
J Rheumatol
|
2007
|
0.84
|
|
22
|
A multicenter reliability study of extremity-magnetic resonance imaging in the longitudinal evaluation of rheumatoid arthritis.
|
J Rheumatol
|
2007
|
0.83
|
|
23
|
OMERACT Rheumatoid Arthritis MRI Studies Module.
|
J Rheumatol
|
2003
|
0.81
|
|
24
|
Update on the OMERACT magnetic resonance imaging task force: research and future directions.
|
J Rheumatol
|
2013
|
0.77
|
|
25
|
The OMERACT MRI inflammatory arthritis group: advances and future research priorities.
|
J Rheumatol
|
2009
|
0.76
|
|
26
|
The OMERACT Magnetic Resonance Imaging Inflammatory Arthritis Group - advances and priorities.
|
J Rheumatol
|
2007
|
0.76
|
|
27
|
Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).
|
J Rheumatol
|
2006
|
0.76
|
|
28
|
Analysis of atherosclerosis with micro-CT.
|
Radiology
|
2005
|
0.75
|